News
European drugmaker Novartis (NVS), best known for blockbuster drugs like Entresto, Cosentyx, and Kesimpta, just announced a major U.S. investment. The $200 billion pharma company intends to invest ...
This spring and summer, Novartis is laying off 427 employees who report to East Hanover, after it let go of 235 staff members at the Morris County site in 2024, according to filings with the New ...
Novartis – East Hanover Effective dates ... Mercer, Middlesex, Monmouth, Morris, and Ocean Effective dates: May 29 to June 12, 2025 Employees impacted: 262 JPMorgan Chase – Jersey City Effective date: ...
after it let go of 235 at the Morris County site last year, filings with the New Jersey Department of Labor show. Novartis has over 3,000 employees working at its campus in East Hanover ...
Novartis secured a $745 million partnership with radiopharmaceutical biotech Ratio Therapeutics to develop a cancer candidate, the companies announced Monday morning. Through the collaboration, ...
Please look at the time stamp on the story to see when it was last updated. MORRIS PLAINS, N.J. (PIX11) — Neighbors in Morris Plains are trying to stop the town from turning an old Friendly’s ...
MORRIS PLAINS – While it may not have been “Mr. Smith Goes to Washington,” it would be accurate to say that Mr. Karr went to Newark seeking resolution for flooding that has long plagued his ...
Novartis is pumping another $180 million into its radioligand plan, handing the cash to serial dealmaker PeptiDream to expand (PDF) a peptide-drug conjugate (PDC) collaboration. Japan’s ...
This past August, the FDA issued an untitled letter (PDF) after an inspection of Novartis’ Morris Plains, New Jersey, manufacturing facility between Nov. 28 and Dec. 9 of last year. In the wake ...
the FDA recapped findings from its inspection of Novartis' Morris Plains, New Jersey, manufacturing facility. The inspection took place at the end of 2022. The FDA notes "significant deviations from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results